Substituted 3,4,5-trimethoxybenzamides: correlation between inhibition of pyruvic acid oxidation and anticonvulsant activity.
D000577:Amides / Q000138:chemical synthesis / Q000494:pharmacology*; D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis / Q000494:pharmacology*; D001565:Benzoates / Q000138:chemical synthesis / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000138:chemical synthesis; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003514:Cyclohexylamines / Q000138:chemical synthesis; D007259:Infrared Rays; D008297:Male; D008738:Methyl Ethers / Q000138:chemical synthesis / Q000494:pharmacology; D010084:Oxidation-Reduction; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011773:Pyruvates / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051381:Rats; D012640:Seizures / Q000517:prevention & control; D013057:Spectrum Analysis
D000577:Amides; D000927:Anticonvulsants; D001565:Benzoates; D001593:Benzyl Compounds; D003514:Cyclohexylamines; D008738:Methyl Ethers; D011773:Pyruvates; D010433:Pentylenetetrazole